Sutura Therapeutics Ltd
Steve Cox is the Founder and CEO of Rair Health Limited, Chief Business Officer at Sutura Therapeutics Ltd, and Managing Director at Elixir Corporate Limited. Steve has a background in healthcare corporate finance and equity research, working with various companies in the biopharmaceutical ecosystem. Cox holds an MBA in Corporate Finance and Banking from Bayes Business School.
Sutura Therapeutics Ltd
Sutura Therapeutics is a biopharmaceutical company at the forefront of developing next-generation biomolecular medicines. Through its innovative drug conjugate platform, Sutura is advancing the field of biomolecular medicine to address the unmet medical needs of patients with diseases which were previously considered undruggable. Biomolecule-based medicines have unique biological properties and actions, which make them promising in treating diseases. However, the size and shape of biomolecules often limit their capacity to enter cells and reach their target, making them less effective. Sutura’s drug conjugates platform is designed to overcome these limitations and has the potential to address a broad range of indications.